European shares suffer worst day since 2016 as virus spreads
LONDON (Reuters) – Europe’s share markets suffered their biggest slump since mid- 2016 on Monday, as a jump in coronavirus cases in Italy, South Korea, Japan and Iran sent investors…
German industrial sectors see supply shortage over virus: BDI
BERLIN (Reuters) – Several sectors of Germany’s manufacturing sector are expecting a shortness of supplies from the Far East region in the coming weeks due to the outbreak of the…
WTO gives somber goods trade outlook, sees virus threat
A traffic light is turned red in front of the WTO headquarters in Geneva, Switzerland, December 10, 2019. REUTERS/Denis Balibouse BRUSSELS (Reuters) – Growth of global trade in goods is…
Chinese support measures buoy world stocks
LONDON (Reuters) – Global shares were buoyant on Monday as the promise of further policy stimulus from China to counteract the economic hit from a coronavirus outbreak calmed nervous investors.…
China shuts transport, temples, Disneyland as virus toll rises to 25
XIANNING, China (Reuters) – China stepped up measures to contain a virus that has killed 25 people and infected more than 800, suspending public transport in 10 cities, shutting temples…
Pharma firms not making enough progress against superbugs: report
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed great enough to tackle the global health threat posed by…
Health warning: How Fitbits can help predict flu outbreaks
LONDON, Jan 16 (Reuters – The Fitbit on your wrist not only counts your steps and minutes of sleep, it can also help tell if you’re coming down with the…
Explainer: Making a new generation of ‘guided-missile’ cancer drugs work
FRANKFURT (Reuters) – A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The therapies are getting a fresh start as dozens of drugmakers…
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
FRANKFURT/ZURICH (Reuters) – Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an…
Novartis, Merck and Allergan join those raising U.S. drug prices for 2020
NEW YORK (Reuters) – Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the…